Metabolic Syndrome Prevalence in Psoriasis

    April 2014 in “ American Journal of Clinical Dermatology ”
    Aurora Parodi, Nicola Aste, Camilla Calvieri, Franca Cantoresi, Marta Carlesimo, Paolo Fabbri, Giorgio Filosa, A. Galluccio, Paolo Lisi, Giuseppe Micali, Concetta Potenza, Antonio Giovanni Richetta, Marco Simonacci, Piergiusto Trevisan, Giancarlo Valenti, Stefano Calvieri
    Image of study
    TLDR People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.
    In a cross-sectional study conducted at 13 dermatological clinics in Italy, researchers found a significantly higher prevalence of Metabolic Syndrome (MetS) in patients with psoriasis compared to a non-psoriatic control group. The study included 720 patients, with 360 in each group. The prevalence of MetS was 26.84% among psoriatic patients versus 15.16% in the control group, with psoriatic patients having nearly double the risk (adjusted odds ratio of 1.96) of being diagnosed with MetS. The study also noted that MetS was associated with greater psoriasis severity and that psoriatic patients had a higher tendency for type 2 diabetes mellitus. These findings underscore the need for comprehensive treatment approaches that address metabolic comorbidities in individuals with psoriasis.
    Discuss this study in the Community →